CA9 and renal cell carcinoma: Compared with other emerging targets for diagnostic and theranostic approaches including carbonic anhydrase 9–directed PET with a reported SUVmax of more than 150 in RCC cases (18), our data suggest FAP to be of subordinate value in renal tumors (19).